MicroQuin
Two pre-clinical, market disruptive technologies that can uniquely hunt out and treat cancers.
- Stage Prototype Ready
- Industry Biotechnology
- Location SF, CA, USA
- Currency USD
- Founded July 2016
- Employees 5
- Incorporation Type C-corp
- Website MicroQuin.com
Company Summary
Microquin is focusing efforts on it’s ‘homing device’ for chemotherapeutics. Our Cell Penetrating Peptide (CPP) can selectively target cancerous cells, including breast, lung, prostate, ovarian and melanoma. This selective targeting means we can deliver a therapeutic cargo, such as chemotherapeutics, to significantly increase their efficacy 2-6x and decreased toxicity between 6-20x, as evidenced both in vitro and in vivo.
Team
-
Founder
Dr Scott Robinson has published multiple papers in world-leading scientific journals. Previously he worked for GlaxoSmithKline where he investigated potential drug candidates through proteomic analysis and target-based drug discovery.
Scott holds a PhD in Cellular and Molecular Biology from Imperial College London and is a Certified Quantitative Analyst -
Founder
Wei Luo currently works at McKinsey & Company, a top global management consulting firm, scaling up business solutions across Europe and Asia Pacific. Prior to that he was in the investment management industry for over 8 years with roles in research, consulting, and business development.
He is a Chartered Financial Analyst and holds a MSc in Accounting and Finance from the LSE. He is also a yoga teacher in training and an avid outdoor adventurist -
Lead EnsellLaboratory DIrector
Ms Ensell currently works in the HER imaging and molecular interaction mapping group at University College London Cancer Institute. Leah has in-depth experience of the drug discovery process and has taken a number of prospective candidates through the discovery pipeline both from a scientific and administrative perspective. Prior to this, she has 10 years of experience as both Laboratory Manager at two of the world’s leading academic institutes.
-
Dr Ellen HigginsonSenior Researcher
-
Chief Creative Officer
Advisors
-
Professor Ann WilliamsUnconfirmedProfessor Charles CoombesUnconfirmedDr Alan BargeUnconfirmed
-
Professor Joshua WangUnconfirmed
Previous Investors
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.